AstraZeneca seeks to move past China probe with Beijing R&D hub
Ever since AstraZeneca shocked investors in October with news its China chief was under investigation, the British pharmaceutical giant has ...
Ever since AstraZeneca shocked investors in October with news its China chief was under investigation, the British pharmaceutical giant has ...
AstraZeneca will invest US$2.5 billion in a new research centre in Beijing, in a major show of commitment to China ...
BRITISH pharmaceutical giant AstraZeneca said on Friday (Jan 31) that it was abandoning plans to build a £450 million (S$756.9 ...
BEIJING’S mayor called on AstraZeneca to expand its research and development investment in the Chinese capital, signalling that a probe ...
It was not immediately clear whether the executive Leon Wang was in the custody of the Chinese governmentAstraZeneca’s China president ...
Anglo-Swedish drugmaker AstraZeneca raised its full year sales and profit forecast on Thursday (Jul 25) after beating analyst expectations for ...
ASTRAZENECA is planning to build a US$1.5 billion facility in Singapore to manufacture antibody drug conjugates (ADCs), or treatments that ...
Experts expect all "monovalent" vaccines, that deal with the original Covid strain, to be withdrawnAstraZeneca has initiated a global withdrawal ...
ASTRAZENECA sailed past market expectations for quarterly revenue and profit on Thursday (Apr 25), boosted by demand for its blockbuster ...
ASTRAZENECA said on Thursday (Apr 11) it intends to increase annual dividend for 2024 by 7 per cent to US$3.10 ...
The NY Journals pride themselves on assembling a proficient and dedicated team comprising seasoned journalists and editors. This collective commitment drives us to provide our esteemed readership with nothing short of the most comprehensive, accurate, and captivating news coverage available.
Transcending the bounds of New York City to encompass a broader scope, we ensure that our audience remains well-informed and engaged with the latest developments, both locally and beyond.
© 2025 The New York Journals. All Rights Reserved.